• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Triple Therapy for Atrial Fibrillation after PCI.

作者信息

Piccini Jonathan P, Jones W Schuyler

机构信息

From the Division of Cardiology, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC.

出版信息

N Engl J Med. 2017 Oct 19;377(16):1580-1582. doi: 10.1056/NEJMe1710753.

DOI:10.1056/NEJMe1710753
PMID:29045197
Abstract
摘要

相似文献

1
Triple Therapy for Atrial Fibrillation after PCI.PCI术后房颤的三联疗法
N Engl J Med. 2017 Oct 19;377(16):1580-1582. doi: 10.1056/NEJMe1710753.
2
Atrial fibrillation: A safe alternative to warfarin plus DAPT after PCI?心房颤动：PCI术后华法林加双联抗血小板治疗的安全替代方案？
Nat Rev Cardiol. 2017 Jan;14(1):4-5. doi: 10.1038/nrcardio.2016.201. Epub 2016 Dec 1.
3
Use and Outcomes of Triple Therapy Among Older Patients With Acute Myocardial Infarction and Atrial Fibrillation.老年急性心肌梗死合并心房颤动患者三联疗法的应用及疗效
J Am Coll Cardiol. 2015 Aug 11;66(6):616-27. doi: 10.1016/j.jacc.2015.05.062.
4
Triple therapy for atrial fibrillation and percutaneous coronary intervention.用于心房颤动和经皮冠状动脉介入治疗的三联疗法。
Curr Opin Cardiol. 2015 Nov;30(6):690-6. doi: 10.1097/HCO.0000000000000228.
5
Total bleeding with rivaroxaban versus warfarin in patients with atrial fibrillation receiving antiplatelet therapy after percutaneous coronary intervention.接受经皮冠状动脉介入治疗后的房颤患者应用氯吡格雷或替格瑞洛双联抗血小板治疗后加用利伐沙班或华法林的出血比较。
J Thromb Thrombolysis. 2018 Oct;46(3):346-350. doi: 10.1007/s11239-018-1703-5.
6
New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint.近期冠状动脉支架置入术后新发房颤：华法林还是非维生素K拮抗剂口服抗凝药加用阿司匹林和氯吡格雷？一种观点。
Int J Cardiol. 2015 Oct 1;196:133-8. doi: 10.1016/j.ijcard.2015.06.006. Epub 2015 Jun 15.
7
Is it Time to Abandon Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation on Anticoagulation?对于正在接受抗凝治疗的房颤患者，经皮冠状动脉介入治疗后是否该放弃双重抗血小板治疗？
JACC Cardiovasc Interv. 2018 Apr 9;11(7):635-637. doi: 10.1016/j.jcin.2017.12.002. Epub 2018 Mar 14.
8
Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.房颤合并冠状动脉疾病患者的三联与双联抗栓治疗
Am J Med. 2016 Jun;129(6):592-599.e1. doi: 10.1016/j.amjmed.2015.12.026. Epub 2016 Jan 18.
9
Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials?非瓣膜性心房颤动患者行经皮冠状动脉介入治疗中的抗血栓治疗：在 PIONEER AF-PCI 和 RE-DUAL PCI 试验之后，我们是否应该改变我们的治疗实践？
Clin Res Cardiol. 2018 Jul;107(7):533-538. doi: 10.1007/s00392-018-1242-2. Epub 2018 Apr 20.
10
Comparison of triple antithrombotic therapy and dual antiplatelet therapy for patients with atrial fibrillation after percutaneous coronary stenting.经皮冠状动脉支架置入术后房颤患者三联抗栓治疗与双联抗血小板治疗的比较
Pak J Pharm Sci. 2016 Sep;29(5 Suppl):1769-1773.

引用本文的文献

1
Is triple antithrombotic therapy a safe option in patients with AF who receive drug-eluting stents?: a review article.三联抗栓治疗对于接受药物洗脱支架的房颤患者来说是一种安全的选择吗？：一篇综述文章。
Egypt Heart J. 2023 Aug 28;75(1):74. doi: 10.1186/s43044-023-00402-0.
2
JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias.《日本循环学会/日本心律学会2020年心律失常药物治疗指南》
J Arrhythm. 2022 Oct 25;38(6):833-973. doi: 10.1002/joa3.12714. eCollection 2022 Dec.
3
Antithrombotic Strategies in Patients with Atrial Fibrillation and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention.
心房颤动合并急性冠状动脉综合征且接受经皮冠状动脉介入治疗患者的抗栓策略
J Clin Med. 2022 Jan 20;11(3):512. doi: 10.3390/jcm11030512.
4
Antithrombotic Strategy in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention.接受经皮冠状动脉介入治疗的心房颤动患者的抗栓策略
J Lipid Atheroscler. 2019 May;8(1):8-14. doi: 10.12997/jla.2019.8.1.8. Epub 2019 May 10.
5
Antithrombotic Strategy for Patients with Acute Coronary Syndrome: A Perspective from East Asia.急性冠状动脉综合征患者的抗栓策略：来自东亚的观点
J Clin Med. 2020 Jun 23;9(6):1963. doi: 10.3390/jcm9061963.
6
Randomised trials and meta-analyses of double vs triple antithrombotic therapy for atrial fibrillation-ACS/PCI: A critical appraisal.心房颤动合并急性冠状动脉综合征/经皮冠状动脉介入治疗中双联与三联抗栓治疗的随机试验和荟萃分析：一项批判性评估。
Int J Cardiol Heart Vasc. 2020 May 14;28:100524. doi: 10.1016/j.ijcha.2020.100524. eCollection 2020 Jun.
7
Ticagrelor or prasugrel . clopidogrel in combination with anticoagulation for treatment of acute coronary syndrome in patients with atrial fibrillation.替格瑞洛或普拉格雷。氯吡格雷联合抗凝治疗心房颤动患者的急性冠状动脉综合征。
Ann Transl Med. 2019 Sep;7(17):406. doi: 10.21037/atm.2019.07.41.
8
When to withhold oral anticoagulation in atrial fibrillation - an overview of frequent clinical discussion topics.心房颤动时何时停用口服抗凝药——常见临床讨论话题概述
Vasc Health Risk Manag. 2019 Sep 17;15:399-408. doi: 10.2147/VHRM.S187656. eCollection 2019.
9
Triple Therapy: When, if Ever?三联疗法：何时（若有必要的话）使用？
Curr Treat Options Cardiovasc Med. 2018 Jul 3;20(7):61. doi: 10.1007/s11936-018-0639-6.
10
Weighing the Anti-Ischemic Benefits and Bleeding Risks from Aspirin Therapy: a Rational Approach.权衡阿司匹林治疗的抗缺血益处和出血风险：一种合理的方法。
Curr Atheroscler Rep. 2018 Feb 21;20(3):15. doi: 10.1007/s11883-018-0717-y.